Aadi Bioscience's market cap is currently $70.63M. The company's EPS TTM is $-2.285; its P/E ratio is ―; Aadi Bioscience is scheduled to report earnings on March 13, 2025, and the estimated EPS forecast is $-0.29. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 24.35M	$ 15.22M	$ 1.00M	$ 14.00M	$ 749.00K
Gross Profit	$ 21.55M	$ 13.88M	$ 724.00K	$ 13.82M	$ 672.50K
Operating Income	$ -71.93M	$ -58.96M	$ -111.22M	$ -2.55M	$ -22.58M
EBITDA	$ -65.36M	$ -60.12M	$ -109.15M	$ -2.48M	$ -24.44M
Net Income	$ -65.77M	$ -57.01M	$ -110.09M	$ -3.48M	$ -23.27M
Balance Sheet
Cash & Short-Term Investments	$ 108.84M	$ 172.56M	$ 148.99M	$ 4.46M	$ 38.52M
Total Assets	$ 132.42M	$ 184.24M	$ 157.91M	$ 18.82M	$ 39.94M
Total Debt	$ 1.27M	$ 1.66M	$ 605.00K	$ 10.26M	$ 169.99K
Net Debt	$ -61.62M	$ -37.36M	$ -148.38M	$ 5.80M	$ -38.35M
Total Liabilities	$ 27.23M	$ 25.86M	$ 21.50M	$ 31.26M	$ 3.40M
Stockholders' Equity	$ 105.19M	$ 158.38M	$ 136.41M	$ -12.43M	$ 36.54M
Cash Flow
Free Cash Flow	$ -63.63M	$ -50.08M	$ -22.47M	$ -12.70M	$ -24.09M
Operating Cash Flow	$ -59.66M	$ -49.64M	$ -22.42M	$ -12.70M	$ -23.85M
Investing Cash Flow	$ 83.21M	$ -132.89M	$ 25.15M	$ -19.02K	$ -236.95K
Financing Cash Flow	$ 326.00K	$ 72.62M	$ 141.80M	$ 1.19M	$ 8.07M

Currency in USD

Aadi Bioscience Earnings and Revenue History

Income Statement >

Aadi Bioscience Debt to Assets

Balance Sheet >

Aadi Bioscience Cash Flow

Cash Flow >

Aadi Bioscience Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing